Merck & Co Inc

Whitehouse Station, New Jersey 088890100

0 studies enrolling now · 3 studies all time

What they study most

HIV Infections

Studies at this site

• A Six-Month Safety and Antiviral Study in HIV-1 Seropositive, AZT-Experienced Patients With CD4 Counts Less Than or Equal to 50 Cells/mm3 to Evaluate MK-639 Alone Versus Zidovudine (AZT) and 3TC Versus the Combination of MK-639 With AZT/3TC — Completed
• A Study of L-735,524 in HIV-Positive Children and Adolescents — Completed
• A Study of Indinavir Sulfate Given Together With Stavudine to HIV-Positive Patients — Completed